Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells
Ashish Misra,
Zhonghui Feng,
Rachana R. Chandran,
Inamul Kabir,
Noemi Rotllan,
Binod Aryal,
Abdul Q. Sheikh,
Ling Ding,
Lingfeng Qin,
Carlos Fernández-Hernando,
George Tellides and
Daniel M. Greif ()
Additional contact information
Ashish Misra: Yale University School of Medicine
Zhonghui Feng: Yale University School of Medicine
Rachana R. Chandran: Yale University School of Medicine
Inamul Kabir: Yale University School of Medicine
Noemi Rotllan: Yale University School of Medicine
Binod Aryal: Yale University School of Medicine
Abdul Q. Sheikh: Yale University School of Medicine
Ling Ding: Yale University School of Medicine
Lingfeng Qin: Yale University School of Medicine
Carlos Fernández-Hernando: Yale University School of Medicine
George Tellides: Yale University School of Medicine
Daniel M. Greif: Yale University School of Medicine
Nature Communications, 2018, vol. 9, issue 1, 1-13
Abstract:
Abstract Smooth muscle cells (SMCs) play a key role in atherogenesis. However, mechanisms regulating expansion and fate of pre-existing SMCs in atherosclerotic plaques remain poorly defined. Here we show that multiple SMC progenitors mix to form the aorta during development. In contrast, during atherogenesis, a single SMC gives rise to the smooth muscle-derived cells that initially coat the cap of atherosclerotic plaques. Subsequently, highly proliferative cap cells invade the plaque core, comprising the majority of plaque cells. Reduction of integrin β3 (Itgb3) levels in SMCs induces toll-like receptor 4 expression and thereby enhances Cd36 levels and cholesterol-induced transdifferentiation to a macrophage-like phenotype. Global Itgb3 deletion or transplantation of Itgb3(−/−) bone marrow results in recruitment of multiple pre-existing SMCs into plaques. Conditioned medium from Itgb3-silenced macrophages enhances SMC proliferation and migration. Together, our results suggest SMC contribution to atherogenesis is regulated by integrin β3-mediated pathways in both SMCs and bone marrow-derived cells.
Date: 2018
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-018-04447-7 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04447-7
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-018-04447-7
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().